Trial Profile
Sitagliptin Trial For Safety And Efficacy In Elderly Patients With Moderately Controlled Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Oct 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms Stream
- 19 Oct 2016 Status changed from active, no longer recruiting to completed.
- 09 Apr 2013 New trial record